In the present study, we showed that FTY720 acts as a SPHK1 inhibitor in vitro and in vivo and that the overexpression of SPHK1 in NPC cells was partially responsible for the suppressive role of FTY720. Here, SPHK1 is linked to nasopharyngeal carcinoma.